Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Feb 08, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-23-000046.pdf 0001883850-23-000046.xls
Feb 07, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-23-000035.pdf 0001883850-23-000035.xls
Feb 07, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-23-000036.pdf 0001883850-23-000036.xls
Feb 07, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-23-000037.pdf 0001883850-23-000037.xls
Feb 06, 2023	10-K	Annual report which provides a comprehensive overview of the company for the past year	View HTML 0001804220-23-000008.pdf 0001804220-23-000008.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Feb 03, 2023	8-K	Report of unscheduled material events or corporate event	View HTML 0001804220-23-000005.pdf 0001804220-23-000005.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Feb 03, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-23-000029.pdf 0001883850-23-000029.xls
Feb 03, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-23-000031.pdf 0001883850-23-000031.xls
Feb 03, 2023	SC 13G/A	An amendment to the SC 13G filing	View HTML 0001306550-23-007818.pdf
Jan 30, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-23-000027.pdf 0001883850-23-000027.xls

Data provided by Kaleidoscope.

Investors & Media